Loading...
XJPX4526
Market cap452mUSD
Jan 21, Last price  
2,323.00JPY
1D
-0.13%
1Q
-11.00%
Jan 2017
-1.78%
Name

Riken Vitamin Co Ltd

Chart & Performance

D1W1MN
XJPX:4526 chart
P/E
8.06
P/S
0.77
EPS
288.38
Div Yield, %
3.92%
Shrs. gr., 5y
-0.10%
Rev. gr., 5y
0.35%
Revenues
91.48b
+3.08%
73,770,000,00079,011,000,00080,821,000,00080,842,000,00078,915,000,00076,550,000,00077,912,000,00075,398,000,00077,568,000,00085,419,000,00085,603,000,00088,072,000,00087,181,000,00089,515,000,00089,888,000,00082,974,000,00077,722,000,00079,231,000,00088,750,000,00091,484,000,000
Net income
8.76b
+36.50%
3,264,000,0002,887,000,0002,004,000,0002,258,000,0001,509,000,0002,584,000,0001,123,000,0001,415,000,0002,406,000,0003,590,000,0003,795,000,0004,129,000,0004,330,000,0005,640,000,0003,949,000,000-7,851,000,000-1,618,000,00021,582,000,0006,414,000,0008,755,000,000
CFO
10.45b
+33.39%
5,137,000,0001,767,000,0006,603,000,0004,860,000,0004,781,000,0006,029,000,0006,840,000,0003,537,000,0003,064,000,0006,908,000,0005,941,000,0008,377,000,0008,126,000,0005,753,000,0006,689,000,0005,850,000,0007,625,000,0006,823,000,0007,835,000,00010,451,000,000
Dividend
Mar 28, 20250 JPY/sh

Profile

Riken Vitamin Co., Ltd. engages in the food ingredient, food application, health care, and chemical businesses in Japan. It offers food emulsifies for use in bread, cake, whipped topping, coffee cream, margarine, tofu, jam, marmalade, ice cream, cocoa, chocolate, noodle, and mashed potato applications; and distilled diglycerine ester, a substance that diglycerine reacts with fatty acids. The company also provides natural tocopherol for retarding oxidation to keep food products fresh; natural food colors; flavors for seasoning, sea food, chicken, and beef products; wakame seaweed that is used in wakame soup, seafood salads, instant noodles, and cup noodle ingredients; and stabilizers and emulsifiers system for frozen desserts and dairy products, as well as bakery emulsifiers and bread improvers, and cake improving agents and emulsifiers. In addition, it offers chemical improving agents, such as glycerol, polyglycerol, sorbitan, propylene glycol, and specialty esters, as well as other agents; and vitamins. The company was formerly known as Riken Vitamin Oil Co., Ltd. and changed its name to Riken Vitamin Co., Ltd. in 1980. Riken Vitamin Co., Ltd. was founded in 1917 and is headquartered in Tokyo, Japan.
URL
https://www.rikenvitamin.jp/
IPO date
Oct 02, 1961
Employees
1,848
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
91,484,000
3.08%
88,750,000
12.01%
79,231,000
1.94%
Cost of revenue
81,854,000
81,396,000
73,173,000
Unusual Expense (Income)
NOPBT
9,630,000
7,354,000
6,058,000
NOPBT Margin
10.53%
8.29%
7.65%
Operating Taxes
3,149,000
1,440,000
(1,285,000)
Tax Rate
32.70%
19.58%
NOPAT
6,481,000
5,914,000
7,343,000
Net income
8,755,000
36.50%
6,414,000
-70.28%
21,582,000
-1,433.87%
Dividends
(2,194,000)
(1,582,000)
(1,385,000)
Dividend yield
2.61%
2.51%
2.52%
Proceeds from repurchase of equity
(6,360,000)
BB yield
7.56%
Debt
Debt current
11,938,000
3,306,000
3,674,000
Long-term debt
4,141,000
11,272,000
13,881,000
Deferred revenue
393,000
316,000
Other long-term liabilities
2,275,000
1,702,000
1,686,000
Net debt
(28,849,000)
(26,915,000)
(23,014,000)
Cash flow
Cash from operating activities
10,451,000
7,835,000
6,823,000
CAPEX
(3,027,000)
(2,167,000)
(3,383,000)
Cash from investing activities
(554,000)
(2,034,000)
(3,661,000)
Cash from financing activities
(7,084,000)
(4,578,000)
(7,565,000)
FCF
5,744,000
4,970,000
(6,100,000)
Balance
Cash
23,384,000
19,155,000
17,302,000
Long term investments
21,544,000
22,338,000
23,267,000
Excess cash
40,353,800
37,055,500
36,607,450
Stockholders' equity
82,129,000
70,535,000
77,248,000
Invested Capital
54,614,200
49,780,500
49,220,550
ROIC
12.42%
11.95%
18.11%
ROCE
9.67%
8.32%
6.89%
EV
Common stock shares outstanding
32,617
32,806
32,800
Price
2,578.00
34.06%
1,923.00
14.67%
1,677.00
22.86%
Market cap
84,086,623
33.29%
63,085,938
14.69%
55,005,600
22.88%
EV
55,267,623
36,196,938
32,010,600
EBITDA
12,960,000
11,072,000
9,794,000
EV/EBITDA
4.26
3.27
3.27
Interest
112,000
132,000
178,000
Interest/NOPBT
1.16%
1.79%
2.94%